Clinical Perspectives on Dose Escalation for Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Clinical Perspectives on Dose Escalation for Non–Small-Cell Lung Cancer

Published:2010-09 Issue:5 Volume:11 Page:299-302
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Chang Albert J.,Bradley Jeffrey D.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresectable NSCLC: RTOG 9410;Curran;Proc Am Soc Clin Oncol,2003

2. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group;Perez;Cancer,1980

3. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients;Le Chevalier;J Natl Cancer Inst,1991

4. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma;Bradley;Int J Radiat Oncol Biol Phys,2005

5. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117;Bradley;Int J Radiat Oncol Biol Phys,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of 18F-FDG PET/CT taken immediately after completion of radiotherapy for lung cancer treated with concurrent chemoradiotherapy: A pilot study;Cancer/Radiothérapie;2022-09

2. Lower Manic Fringe Expression as an Independent Prognostic Biomarker and Correlated with Immune Suppression of Tumor Microenvironment in Lung Adenocarcinoma;Indian Journal of Pharmaceutical Sciences;2022

3. Cost-effectiveness of patient-specific motion management strategy in lung cancer radiation therapy planning;The Engineering Economist;2019-04-23

4. Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up];European Journal of Nuclear Medicine and Molecular Imaging;2019-03-13

5. Radiation therapy-induced metastasis: radiobiology and clinical implications;Clinical & Experimental Metastasis;2017-11-20